CVE-2023-26546

CVE-2023-26546 is a high-severity vulnerability in Echa.europa Iuclid with a CVSS 3.x base score of 8.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-94.

Key facts

Description

European Chemicals Agency IUCLID before 6.27.6 allows remote authenticated users to execute arbitrary code via Server Side Template Injection (SSTI) with a crafted template file. The attacker must have template manager permission.

Frequently asked questions

What is CVE-2023-26546?
European Chemicals Agency IUCLID before 6.27.6 allows remote authenticated users to execute arbitrary code via Server Side Template Injection (SSTI) with a crafted template file. The attacker must have template manager permission.
How severe is CVE-2023-26546?
CVE-2023-26546 has a CVSS 3.x base score of 8.8, rated high severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2023-26546 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (70th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-26546?
CVE-2023-26546 affects Echa.europa Iuclid. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2023-26546?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2023-26546 published?
CVE-2023-26546 was published on 2023-05-02 and last updated on 2026-06-17.

References

Affected products (1)

More vulnerabilities in Echa.europa Iuclid

All CVEs affecting Echa.europa Iuclid →

Other CWE-94 (Code Injection) vulnerabilities

Browse all CWE-94 (Code Injection) vulnerabilities →